{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T06:58:16Z","timestamp":1785653896908,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008209","name":"University at Buffalo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.msard.2025.106695","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T08:45:05Z","timestamp":1755506705000},"page":"106695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluating the role of anti-EBV antibodies as biomarkers for the evolution of multiple sclerosis: A longitudinal study"],"prefix":"10.1016","volume":"103","author":[{"given":"Mehak","family":"Semy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Tranquille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Bergsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Jakimovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Bartnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack A.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Weinstock-Guttman","family":"B","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-1485","authenticated-orcid":false,"given":"Robert","family":"Zivadinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106695_bib0001","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2025.106695_bib0002","first-page":"988","article-title":"Epidemiology and pathophysiology of Multiple sclerosis","volume":"28","author":"Ward","year":"2022","journal-title":"Continuum (Minneap. Minn.)"},{"key":"10.1016\/j.msard.2025.106695_bib0003","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/1744666X.2024.2328739","article-title":"How to and should we target EBV in MS?","volume":"20","author":"Eckert","year":"2024","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.msard.2025.106695_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1384411","article-title":"A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression","volume":"15","author":"Dominguez-Mozo","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106695_bib0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.msard.2025.106695_bib0006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/1673-5374.245462","article-title":"The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging","volume":"14","author":"Guan","year":"2019","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.msard.2025.106695_bib0007","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.msard.2025.106695_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1487523","article-title":"In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis","volume":"15","author":"Vasilenko","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106695_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192109","article-title":"Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells","volume":"13","author":"Hassani","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2025.106695_bib0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1352458519872664","article-title":"Environmental factors and risk of multiple sclerosis: findings from meta-analyses and mendelian randomization studies","volume":"26","author":"Belbasis","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106695_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.991662","article-title":"Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: a two-years longitudinal study","volume":"13","author":"Dominguez-Mozo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106695_bib0012","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029058","article-title":"Biomarkers in multiple sclerosis","volume":"9","author":"Paul","year":"2019","journal-title":"Cold Spring Harb. Perspect Med."},{"key":"10.1016\/j.msard.2025.106695_bib0013","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1212\/NXI.0000000000000190","article-title":"Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS","volume":"3","author":"Zivadinov","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106695_bib0014","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.2008.154906","article-title":"Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis","volume":"80","author":"Zivadinov","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106695_bib0015","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1177\/1352458514533843","article-title":"Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis","volume":"20","author":"Kvistad","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106695_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175279","article-title":"Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis","volume":"12","author":"Gie\u00df","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2025.106695_bib0017","doi-asserted-by":"crossref","first-page":"e1950","DOI":"10.1212\/WNL.0000000000009371","article-title":"Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT","volume":"94","author":"Cortese","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106695_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105410","article-title":"Evaluating the clinical utility of Epstein-Barr Virus antibodies as biomarkers in multiple sclerosis: a systematic review","volume":"84","author":"Bose","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106695_bib0019","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein-Barr Virus in multiple sclerosis: theory and emerging immunotherapies","volume":"26","author":"Bar-Or","year":"2020","journal-title":"Trends. Mol. Med."},{"key":"10.1016\/j.msard.2025.106695_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/901312","article-title":"Epstein-Barr virus specific antibody response in multiple sclerosis patients during 21 months of Natalizumab treatment","volume":"2015","author":"Castellazzi","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.msard.2025.106695_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101388","article-title":"Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis","volume":"36","author":"Zivadinov","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106695_bib0022","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/ene.13769","article-title":"Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study","volume":"26","author":"Jakimovski","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106695_bib0023","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210004","article-title":"Associations between paramagnetic rim lesion evolution and clinical and radiologic disease progression in persons with multiple sclerosis","volume":"103","author":"Reeves","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106695_bib0024","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2025.106695_bib0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuroimage.2011.07.045","article-title":"Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study","volume":"59","author":"Zivadinov","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.msard.2025.106695_bib0026","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00415-021-10855-5","article-title":"Correction to: FLAIR(2) post-processing: improving MS lesion detection in standard MS imaging protocols","volume":"269","author":"Zrzavy","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106695_bib0027","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221425","article-title":"Multicenter evaluation of AI-generated DIR and PSIR for cortical and juxtacortical Multiple sclerosis lesion detection","volume":"307","author":"Bouman","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.msard.2025.106695_bib0028","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jon.13088","article-title":"T(1) \/T(2) ratio from 3T MRI improves multiple sclerosis cortical lesion contrast","volume":"33","author":"Manning","year":"2023","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.msard.2025.106695_bib0029","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","article-title":"N4ITK: improved N3 bias correction","volume":"29","author":"Tustison","year":"2010","journal-title":"IEEe Trans. Med. ImAging"},{"key":"10.1016\/j.msard.2025.106695_bib0030","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/hbm.21402","article-title":"The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis","volume":"33","author":"Gelineau-Morel","year":"2012","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.msard.2025.106695_bib0031","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/nimg.2002.1132","article-title":"Improved optimization for the robust and accurate linear registration and motion correction of brain images","volume":"17","author":"Jenkinson","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.msard.2025.106695_bib0032","doi-asserted-by":"crossref","unstructured":"Michael Dwyer RZ, Niels Bergsland, Alexander Bartnik, Dejan Jakimovski, Samantha Noteboom, Menno Schoonheim, Martijn Steenwijk, Jinglan Pei, David Clayton, Robert Zivadinov. Quantifying cortical lesions in large legacy multiple sclerosis clinical trial MRI datasets using multi-contrast post-processing and deep learning. 2025.","DOI":"10.1101\/2025.04.08.25325461"},{"key":"10.1016\/j.msard.2025.106695_bib0033","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/WNL.0b013e31820a0cc4","article-title":"Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI","volume":"76","author":"Geurts","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106695_bib0034","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nimg.2002.1040","article-title":"Accurate, robust, and automated longitudinal and cross-sectional brain change analysis","volume":"17","author":"Smith","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.msard.2025.106695_bib0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00004728-200105000-00022","article-title":"Normalized accurate measurement of longitudinal brain change","volume":"25","author":"Smith","year":"2001","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.msard.2025.106695_bib0036","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/hbm.22237","article-title":"Validation of the automated method VIENA: an accurate, precise, and robust measure of ventricular enlargement","volume":"35","author":"Vrenken","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.msard.2025.106695_bib0037","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2013.12.004","article-title":"Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model","volume":"90","author":"Dwyer","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.msard.2025.106695_bib0038","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jns.2009.04.010","article-title":"Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study","volume":"282","author":"Frohman","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106695_bib0039","first-page":"1757","article-title":"Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal MRI study","volume":"6","author":"Jakimovski","year":"2019","journal-title":"Ann. Clin. Transl. Sci."},{"key":"10.1016\/j.msard.2025.106695_bib0040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","article-title":"Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106695_bib0041","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/ane.12268","article-title":"EBV & HHV6 reactivation is infrequent and not associated with MS clinical course","volume":"130","author":"Simpson","year":"2014","journal-title":"Acta Neurol. Scand"},{"key":"10.1016\/j.msard.2025.106695_bib0042","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/WCO.0000000000001152","article-title":"Imaging cortical lesions in multiple sclerosis","volume":"36","author":"Mainero","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.msard.2025.106695_bib0043","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/13524585241229956","article-title":"Paramagnetic rim lesions predict greater long-term relapse rates and clinical progression over 10 years","volume":"30","author":"Reeves","year":"2024","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106695_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2023.1234572","article-title":"Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration","volume":"4","author":"Thakolwiboon","year":"2023","journal-title":"Front. Aging"},{"key":"10.1016\/j.msard.2025.106695_bib0045","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1177\/11206721241230567","article-title":"New insights in the pathogenic mechanism of multiple sclerosis: is Epstein-Barr virus associated with optic nerve involvement?","volume":"34","author":"Remoli-Sargues","year":"2024","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.msard.2025.106695_bib0046","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/CVI.00674-15","article-title":"Kinetics of Epstein-Barr Virus (EBV) neutralizing and virus-specific antibodies after primary infection with EBV","volume":"23","author":"Bu","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.msard.2025.106695_bib0047","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3389\/fneur.2019.01232","article-title":"Not systemic inflammation is correlated with multiple sclerosis severity, Especially in Progressive Multiple Sclerosis","volume":"10","author":"Milstein","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106695_bib0048","doi-asserted-by":"crossref","first-page":"e1451","DOI":"10.1002\/cti2.1451","article-title":"Epstein-Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism","volume":"12","author":"Thomas","year":"2023","journal-title":"Clin. Transl. Immunology."},{"key":"10.1016\/j.msard.2025.106695_bib0049","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200427","article-title":"Exploring the clinical utility of neurofilament light chain assays in multiple sclerosis management","volume":"12","author":"Bar-Or","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825004377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825004377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:17:37Z","timestamp":1774999057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825004377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":49,"alternative-id":["S2211034825004377"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106695","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the role of anti-EBV antibodies as biomarkers for the evolution of multiple sclerosis: A longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106695"}}